Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin plus FOLFOX4 in oxaliplatin-resistant metastatic colorectal cancer
ChiCTR-ONC-12001907Phase 2Completed
- Sponsor
- Suzhou Dushu Lake Hospital
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aspirin in colorectal cancer (CRC), sponsored by Suzhou Dushu Lake Hospital. Primary endpoint: Effect rate. Started Jan 2009; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR-ONC-12001907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12001907.